Lethargy: Clinical Trials

4 trials for Lethargy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4

Follow Lethargy: new trials by email Literature Review of Lethargy trials Research Report on Lethargy

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Apathy in Dementia Methylphenidate Trial 2
Methylphenidate, Placebo - Apathy, Alzheimer's Disease
Phase 3CompletedJohns Hopkins Bloomberg School of Public Health2002016-01-012023-06-13
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Brexpiprazole - Schizophrenia
Phase 3CompletedOtsuka Pharmaceutical Development & Commercialization, Inc.492013-11-012016-03-29
Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia
rivastigmine, placebo - Parkinson's Disease, Apathy
Phase 3CompletedUniversity Hospital, Lille402009-03-012012-04-24
Treatment of Apathy in Alzheimer's Disease With Modafinil
Modafinil, Placebo - Apathy, Alzheimer's Disease
Phase 3CompletedBrown University222005-07-012011-03-04

Narrower conditions

Alzheimer Disease (2)  ·  Caregiver Burden (1)  ·  Mental Disorders (1)  ·  Parkinson Disease (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)

Broader conditions

Nervous System Diseases (4)  ·  Neurobehavioral Manifestations (4)  ·  Neurologic Manifestations (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Neurodegenerative Diseases (3)  ·  Dementia (2)  ·  Mental Disorders (2)  ·  Neurocognitive Disorders (2)  ·  Tauopathies (2)  ·  Basal Ganglia Diseases (1)  ·  Behavior (1)  ·  Behavioral Symptoms (1)

Interventions

Cholinesterase Inhibitors (1)  ·  Methylphenidate (1)  ·  Modafinil (1)  ·  Rivastigmine (1)  ·  Transdermal Patch (1)  ·  brexpiprazole (1)

Sponsors

Brown University (1)  ·  Johns Hopkins Bloomberg School of Public Health (1)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (1)  ·  University Hospital, Lille (1)

Countries

United States (3)  ·  Canada (1)  ·  France (1)

Top investigators

David Devos, MD, PhD (1)  ·  Jacobo Mintzer, MD (1)  ·  Junichi Hashimoto, PhD (1)  ·  Laura L Frakey, Ph.D. (1)

Results publications

PMID 22687392, PMID 24218528, PMID 29347996, PMID 34570180, PMID 37066690, PMID 41521126

NIH funding

2008 (1), F32MH075583 (1), R01AG046543 (1)